An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

By I. Frank, M. Blute, John C. Cheville, Christine M. Lohse, A. Weaver, H. Zincke. Journal of Urology, 2002

1,154 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/088d2e190cb9cab1f833e701d3ce4c0ea4a05129

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Pedro C. Barata
2. B. Rini

In Pulmonary and Respiratory Medicine

1. Pedro C. Barata
2. B. Rini

In Surgery

1. Pedro C. Barata
2. B. Rini

Citations in the corpus

• Treatment of renal cell carcinoma: Current status and future directions (2017, methodology): “One score, the SSIGN, was developed at the Mayo Clinic (also known as the Leibovich score) and classified patients with ccRCC into low-risk, intermediate-risk, or high-risk categories, according to stage, tumor size, nuclear grade, and the presence of tumor necrosis.(17,18) This score has been exter”
• EAU guidelines on renal cell carcinoma: 2014 update. (2010, neutral): “For localised RCC, several risk scores and nomograms can be used, including the Stage, Size, Grade, and Necrosis Score (SSIGN) [44], a modified version of the SSIGN score (Leibovich score) [45] , and Karakiewicz's nomogram (LE 3) [47]; Section 3.7 provides further details.”